Exploring the role of the FGF19/FGFR4 signaling pathway in breast cancer drug resistance, developing specific targeted drugs, optimizing combination therapy strategies, and exploring new treatment technologies are expected to offer more effective treatment options for breast cancer patients and help overcome the challenge of drug resistance. The gene discussed is FGFR4; the disease is breast cancer.